Skip to main content
. 2002 Mar;53(3):243–249. doi: 10.1046/j.0306-5251.2001.01560.x

Table 1.

Demographic data and results of screening procedures for the 24 subjects who completed the study.*

Maximum tolerated dose (mg day−1)
Subject Age (years) Gender FEV1 (% predicted) Diltiazem Nifedipine
01 26 M 47 360 160
03 23 F 100 360 80
04 21 F 96 360 40
05 24 F 89 360 120
06 20 F 84 360 80
07 38 M 52 240 80
08 24 F 60 360 80
09 25 M 68 360 80
10 23 M 75 480 120
11 23 M 71 360 80
12 22 M 47 480 80
13 19 F 94 480 120
14 32 M 60 360 80
15 35 M 98 480 120
16 24 M 78 480 120
17 20 F 60 480 120
18 22 F 66 480 40
20 26 M 71 240 40
21 18 M 63 360 80
23 22 F 91 360 40
24 24 M 82 360 40
25 23 M 91 480 80
27 24 F 68 360 160
30 24 F 100 360 40
Mean 24 13M/11F 75 390 87
s.e. mean 1 3 15 7
*

Three of the subjects were excluded from final data analysis because of packaging errors in the blinded treatments.